f
  1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Neurotensin Receptor

Neurotensin Receptor

The neuropeptide neurotensin (NT) exerts central actionsthat include hypothermia, analgesia, and a number of effects that involve the modulation of nigrostriatal and mesocortico-limbic dopaminergic pathways. The two neurotensin receptor subtypes known to date, NTR1 and NTR2, belong to the family of G-protein-coupled receptors with seven putative transmembrane domains (TM). The NTR1 has high affinity for neurotensin, whereas the NTR2 has lower affinity for the peptide and is selectively recognized by levocabastine, an anti-histamine H1 receptor antagonist. These receptors have widespread, though not identical, central and peripheral distributions and exhibit distinct ontogenic profiles.

It is notably reported that NTR1 activation results in significant antinociception but also causes marked hypotension and hypothermia. In sharp contrast, NTR2 has emerged as an important pain target because NTR2-selective analogues exhibit potent analgesic activity in both acute and chronic pain conditions in dose-dependent analgesic effects without inducing drop in blood pressure or body temperature.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-159878
    SORT1-IN-5
    Inhibitor
    SORT1-IN-5 (compound 3) is a blood-brain barrier permeable SORT1 inhibitor. SORT1-IN-5 is an MSOH salt with limited oral bioavailability.
    SORT1-IN-5
  • HY-RS09642
    Ntsr2 Mouse Pre-designed siRNA Set A
    Inhibitor

    Ntsr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ntsr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ntsr2 Mouse Pre-designed siRNA Set A
    Ntsr2 Mouse Pre-designed siRNA Set A
  • HY-RS09643
    Ntsr2 Rat Pre-designed siRNA Set A
    Inhibitor

    Ntsr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ntsr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Ntsr2 Rat Pre-designed siRNA Set A
    Ntsr2 Rat Pre-designed siRNA Set A
  • HY-P0066
    Contulakin G
    Agonist
    Contulakin G is an O-glycosylated invertebrate neurotensin. Contulakin-G is a weaker agonist for the neurotensin receptor. Contulakin G is also a potent antinociceptive agent.
    Contulakin G
  • HY-149941
    hNTS1R agonist-1
    Agonist
    hNTS1R agonist-1 (Compound 10) is a BBB permeable hNTS1R full agonist (Ki: 6.9 nM) . hNTS1R agonist-1 increases motor function and memory in a mouse model of Parkinson's disease (PD). hNTS1R agonist-1 is a Neurotensin(8-13) analog and is a neuroprotective agent.
    hNTS1R agonist-1
  • HY-P10767
    MD01-67
    Activator
    MD01-67 is a selective macrocyclic compound targeting the neurotensin receptor type 2 (NTS2), with Ki of 2.9 nM. MD01-67 exhibits analgesic and tactile hypersensitivity reducing activity in rats acute/persistent/chronic inflammatory pain models.
    MD01-67
  • HY-RS09641
    NTSR2 Human Pre-designed siRNA Set A
    Inhibitor

    NTSR2 Human Pre-designed siRNA Set A contains three designed siRNAs for NTSR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    NTSR2 Human Pre-designed siRNA Set A
    NTSR2 Human Pre-designed siRNA Set A
  • HY-159877
    SORT1-IN-4
    Inhibitor
    SORT1-IN-4 (compound 6) is a blood-brain barrier permeable SORT1 inhibitor.
    SORT1-IN-4
  • HY-164795A
    SBI-810 hydrochloride
    Modulator 99.11%
    SBI-810 hydrochloride is a functionally selected β-arrestin-biased neurotensin receptor 1 (NTSR1) allosteric modulator. SBI-810 hydrochloride modulates NTSR1 G protein signaling in a G protein-specific manner in the presence of the endogenous ligand, neurotensin (NT). SBI-810 hydrochloride fully antagonizes NT-induced activation of Gq, partially antagonizes NT-induced activation of Gi1 and is permissive of NTSR1 activation of GoA and G12.
    SBI-810 hydrochloride
  • HY-170531
    SR 142948-C3-NHMe
    SR 142948-C3-NHMe is the methylated SR 142948 (HY-107664).
    SR 142948-C3-NHMe
  • HY-P1256
    JMV 449
    Agonist
    JMV 449 is a potent neurotensin receptor agonist. JMV 449 shows an IC50 of 0.15 nM for inhibition of [125I]-neurotensin binding to neonatal mouse brain and an EC50 of 1.9 nM in contracting the guinea-pig ileum. JMV 449 has highly potent and long-lasting hypothermic and analgesic effects in the mouse.
    JMV 449
  • HY-159875
    SORT1-IN-2
    Inhibitor
    SORT1-IN-2 (compound 6) is a SORT1 inhibitor.
    SORT1-IN-2
  • HY-14277AR
    Levocabastine (hydrochloride) (Standard)
    Antagonist
    Levocabastine (hydrochloride) (Standard) is the analytical standard of Levocabastine (hydrochloride). This product is intended for research and analytical applications. Levocabastine (R 50547) hydrochloride is a potent and selective histamine H1-receptor antagonist. Levocabastine hydrochloride is also a selective, high affinity neurotensin receptor subtype 2 (NTR2) antagonist, with a Ki of 17 nM for mNTR2. Levocabastine hydrochloride can act as a VLA-4 antagonist, interferes with conjunctival eosinophil infiltration in allergic conjunctivitis (AC).
    Levocabastine (hydrochloride) (Standard)
  • HY-129793
    L-156903
    Inhibitor
    L-156903 potently inhibits neurotensin (NT) binding to brain tissue.
    L-156903
  • HY-124831
    NTRC-844
    Antagonist
    NTRC-844 (compound 8) is a selective antagonist of neurotensin receptor type 2 (NTS2),with the EC50 of 238 nM. NTRC-844 plays an important role in analgesic animal research.
    NTRC-844
Cat. No. Product Name / Synonyms Application Reactivity

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.